Luxor Capital Group’s Healthcare Services Acquisition Corporation Warrant HCARW Stock Holding History

Luxor Capital Group’s Portfolio HCARW Stock Details HCARW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-187,095	Closed	-$6K	–	101
2022 Q3	$6K	Sell	187,095 -404	-0.2%	-$23	﹤0.01%	83
2022 Q2	$19K	Buy	+187,499	New	+$33.1K	﹤0.01%	87
2022 Q1	–	Sell	-187,499	Closed	-$80.5K	–	159
2021 Q4	$97K	Buy	+187,499	New	+$120K	﹤0.01%	126

Luxor Capital Group's HCARW Position: Q4 2022 in Review

Luxor Capital Group sold out of Healthcare Services Acquisition Corporation Warrant (HCARW) in Q4 2022, closing a stake of 187,095 shares — an estimated $6K sold.

Luxor Capital Group first reported a position in HCARW in Q4 2021 and held it in 3 quarters. The position peaked at $97K in Q4 2021. 0 funds tracked by Wall St. Rank hold HCARW as of Q4 2022.

Luxor Capital Group reported no remaining Healthcare Services Acquisition Corporation Warrant position as of Q4 2022 after selling out during the quarter.
Luxor Capital Group sold 187,095 Healthcare Services Acquisition Corporation Warrant shares in Q4 2022, an estimated $6K.
Luxor Capital Group first reported a position in Healthcare Services Acquisition Corporation Warrant in Q4 2021 and held it in 3 quarters.
Luxor Capital Group's Healthcare Services Acquisition Corporation Warrant position peaked at $97K in Q4 2021.
0 funds tracked by Wall St. Rank held Healthcare Services Acquisition Corporation Warrant as of Q4 2022.

Based on Luxor Capital Group's 13F filing for Q4 2022, filed 14 Feb 2023.